Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Doximity Inc Cl A (NY: DOCS )

27.88 -0.64 (-2.24%)
Streaming Delayed Price Updated: 2:03 PM EDT, May 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Doximity Inc Cl A

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
NYSE:DOCS—A High-Growth Stock Gearing Up for Its Next Upward Move.
Why DOXIMITY INC-CLASS A (NYSE:DOCS) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
Despite its growth, NYSE:DOCS remains within the realm of affordability.
NYSE:DOCS is not too expensive for the growth it is showing. 
Via Chartmill
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
Via Benzinga
NYSE:DOCS is showing decent growth, but is still valued reasonably.
Looking for growth without the hefty price tag? Consider DOXIMITY INC-CLASS A (NYSE:DOCS). 
Via Chartmill
Crude Oil Gains 1%; GameStop Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Stocks Flat As Market Heads For Winning Week
Stocks are fairly quiet today, with all three major benchmarks near breakeven after yesterday's intraday record highs, but now in positive territory for the second quarter. 
Via Talk Markets
NYSE:DOCS qualifies as a high growth stock and is consolidating.
DOXIMITY INC-CLASS A (NYSE:DOCS)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
6 Analysts Assess Doximity: What You Need To Know
Via Benzinga
NYSE:DOCS—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via Chartmill
6 Analysts Assess Doximity: What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Gold Gains 1%; RBC Bearings Shares Rise After Q4 Results
Via Benzinga
Why Doximity Stock Is Skyrocketing Today
Investors found a lot to like about the healthcare technology company's latest quarterly update. 
Via The Motley Fool
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
Via Benzinga
Why Doximity Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NYSE:DOCS, a growth stock which is not overvalued.
Investors should take note ofDOXIMITY INC-CLASS A (NYSE:DOCS), a growth stock that remains attractively priced. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Wall Street Stays Cautious To Close Out A Big Week, Meme Rally Resumes: Analyst Warns Investors 'Not To Sprint On The Victory Lap'
U.S. stocks are poised for a cautious start on Friday as concerns about rising interest rates return. Traders are waiting for a significant catalyst to propel the market higher after its recent record... 
Via Benzinga
Applied Materials, RBC Bearings And 3 Stocks To Watch Heading Into Friday
Via Benzinga
DOCS Stock Earnings: Doximity Beats EPS, Beats Revenue for Q4 2024
DOCS stock results show that Doximity beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
What 6 Analyst Ratings Have To Say About Doximity
Via Benzinga
NYSE:DOCS—A High-Growth Stock Gearing Up for Its Next Upward Move.
Why DOXIMITY INC-CLASS A (NYSE:DOCS) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
NYSE:DOCS stands out as a growth opportunity that won't break the bank.
Investors seeking growth at a reasonable cost should explore NYSE:DOCS. 
Via Chartmill
Doximity Stock Jumps 10% On Q4 Earnings: What You Need To Know
Doximity's fourth-quarter revenue increased 6% year-over-year to $118.1 million, which beat the consensus estimate of $116.4 million, according to Benzinga Pro. The company reported adjusted earnings... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
2 No-Brainer Growth Stocks Down 29% and 22% to Buy Hand Over Fist Right Now
These businesses are generating strong momentum, despite what share prices might indicate. 
Via The Motley Fool
For those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering.
DOXIMITY INC-CLASS A (NYSE:DOCS) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
HIMS Stock Breaks Out On Powerful Turnaround Quarter
"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.